FIELD: pharmacology.
SUBSTANCE: invention is an o-benzoylaminobenzoic acid derivative of the following formula
,
which has a bacteriostatic and bactericidal activity against M. lufu.
EFFECT: drug is low-toxic and has the ability to suppress the reproduction of mycobacteria.
1 ex, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
N,N'-(SULFONYLDI-1,4-PHENYLENE)-BIS-(N'',N''-DIMETHYLFORM- -AMIDINE)-1,2,3,4-TETRAHYDRO-6-METHYL-2,4-DIOXO-5-PYRIMIDINE SULFONATE STIMULATING CELLULAR METABOLISM AND SHOWING IMMUNOTROPIC AND ANTIBACTERIAL ACTIVITY | 1997 |
|
RU2136668C1 |
METHOD OF LEPROSY DIAGNOSIS | 1996 |
|
RU2124730C1 |
SULPHONIC 2-NITRO-2-(3-ARYL-1,2,4-OXADIAZOLE-5-YL)ETHANE DERIVATIVES EXHIBITING ANTILEPROTIC AND ANTITUBERCULOUS ACTIVITY | 2009 |
|
RU2415845C1 |
OROTATE OF N, П,П'-DIAMINODIPHENYL SULFONE HAVING ANTILEPROSOUS AND IMMUNOTROPIC ACTIVITY | 1995 |
|
RU2074856C1 |
METHOD OF IMMUNOPROPHYLAXIS OF EXPERIMENTAL LEPROSY INFECTION | 1996 |
|
RU2135196C1 |
METHOD FOR EVALUATING EFFICIENCY OF ANTILEPROUS MEDICINAL PREPARATIONS | 2003 |
|
RU2242761C1 |
ANTI-TUBERCULOSIS AGENT BASED ON N-[4-(4-AMINOBENZSULFANYL)-PHENYL-2-BENZOYLAMINOBENZAMIDE WITH LOW TOXICITY | 2018 |
|
RU2683573C1 |
METHOD FOR Mycobacterium leprae ANTIBODY TEST | 2012 |
|
RU2500423C1 |
METHOD FOR Mycobacterium leprae ANTIBODY TEST | 2012 |
|
RU2501022C2 |
METHOD FOR MODELING LEPROSY | 1993 |
|
RU2098866C1 |
Authors
Dates
2017-12-19—Published
2016-06-02—Filed